Desmethoxycurcumin aids IFNα’s anti-HBV activity by antagonising CRYAB reduction and stabilising IFNAR1 protein

Interleukin-17A pretreatment attenuates the anti-hepatitis B virus efficacy of interferon-alpha by reducing activation of the interferon-stimulated gene factor 3 transcriptional complex in hepatitis B virus-expressing HepG2 cells

(2022) Jiaxuan Zhang et al.   Virology Journal

Curcumin assists anti-EV71 activity of IFN-α by inhibiting IFNAR1 reduction in SH-SY5Y cells

(2022) Yanfang Wang et al.   Gut Pathogens

How to achieve functional cure of HBV: Stopping NUCs, adding interferon or new drug development?

(2022) Grace L.H. Wong et al.   JOURNAL OF HEPATOLOGY

Hepatitis B Virus-Associated Hepatocellular Carcinoma

(2022) Giacomo Emanuele Maria Rizzo et al.   Viruses-Basel

Interferon and interferon-stimulated genes in HBV treatment

(2022) Qirong Li et al.   Frontiers in Immunology

Estimating the attributable fraction of cirrhosis and hepatocellular carcinoma due to hepatitis B and C

(2021) Erika Duffell et al.   JOURNAL OF VIRAL HEPATITIS

AlphaB-crystallin promotes porcine circovirus type 2 replication in a cell proliferation-dependent manner

(2021) Rongdi Luo et al.   VIRUS RESEARCH

Innate immunity and HBV persistence

(2021) Carolina Chiale et al.   Current Opinion in Virology

ProspeCtive study to evaluate efficacy, safety and tOlerability of dietary supplemeNT of Curcumin (BCM95) in subjects with Active relapsing MultIple Sclerosis treated with subcutaNeous Interferon beta 1a 44 mcg TIW (CONTAIN): a randomized, controlled trial...

(2021) Maria Petracca et al.   Multiple Sclerosis and Related Disorders

Interferon and Hepatitis B: Current and Future Perspectives

(2021) Jianyu Ye et al.   Frontiers in Immunology

Effects of Curcumin Analogues DMC and EF24 in Combination with the Cytokine TRAIL against Kidney Cancer

(2021) Verónica Ibáñez Gaspar et al.   MOLECULES

Curcumin inhibited hepatitis B viral entry through NTCP binding

(2021) Piyanoot Thongsri et al.   Scientific Reports

Current epidemiology in hepatocellular carcinoma

(2021) Peter Konyn et al.   Expert Review of Gastroenterology & Hepatology

SynergyFinder 2.0: visual analytics of multi-drug combination synergies

(2020) Aleksandr Ianevski et al.   NUCLEIC ACIDS RESEARCH

Mechanisms of HBV immune evasion

(2020) Adrian Kuipery et al.   ANTIVIRAL RESEARCH

Hepatitis B virus persistence and reactivation

(2020) Yu Shi et al.   BMJ-British Medical Journal

Demethoxycurcumin: A naturally occurring curcumin analogue for treating non‐cancerous diseases

(2019) Mahdi Hatamipour et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Inhibition of TLR4/TRIF/IRF3 Signaling Pathway by Curcumin in Breast Cancer Cells

(2019) Gamze Güney Eskiler et al.   JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES

Matrix Metalloproteinase 9 Facilitates Hepatitis B Virus Replication through Binding with Type I Interferon (IFN) Receptor 1 To Repress IFN/JAK/STAT Signaling

(2017) Junbo Chen et al.   JOURNAL OF VIROLOGY

Baculovirus LEF-11 nuclear localization signal is important for viral DNA replication

(2017) Tingting Chen et al.   VIRUS RESEARCH

Curcumin inhibits hepatitis B virus infection by down-regulating cccDNA-bound histone acetylation

(2017) Zhi-Qiang Wei et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Phosphorylation and degradation of αB-crystallin during enterovirus infection facilitates viral replication and induces viral pathogenesis

(2017) Gabriel Fung et al.   Oncotarget

αB-Crystallin Interacts with Nav1.5 and Regulates Ubiquitination and Internalization of Cell Surface Nav1.5

(2016) Yuan Huang et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

HBV cccDNA: viral persistence reservoir and key obstacle for a cure of chronic hepatitis B

(2015) Michael Nassal   GUT

Pegylated interferon alfa for chronic hepatitis B: systematic review and meta-analysis

(2015) V. Kim et al.   JOURNAL OF VIRAL HEPATITIS

Spinoculation Enhances HBV Infection in NTCP-Reconstituted Hepatocytes

(2015) Ran Yan et al.   PLoS One

Poly(I:C) Treatment Leads to Interferon-Dependent Clearance of Hepatitis B Virus in a Hydrodynamic Injection Mouse Model

(2014) J. Wu et al.   JOURNAL OF VIROLOGY

Alpha beta-crystallin expression and presentation following infection with murine gammaherpesvirus 68

(2013) Vinita S. Chauhan et al.   AUTOIMMUNITY

Poly(I:C)/Alum Mixed Adjuvant Priming Enhances HBV Subunit Vaccine-Induced Immunity in Mice When Combined with Recombinant Adenoviral-Based HBV Vaccine Boosting

(2013) Xia Chuai et al.   PLoS One

Beneficial effects of curcumin on GFAP filament organization and down-regulation of GFAP expression in an in vitro model of Alexander disease

(2012) Tiziana Bachetti et al.   EXPERIMENTAL CELL RESEARCH

Hepatitis B virus X protein inhibits extracellular IFN-α-mediated signal transduction by downregulation of type I IFN receptor

(2012) IL-RAE CHO et al.   INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE

Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus

(2012) Huan Yan et al.   eLife

The expressions of HSP70 and αB-crystallin in myocarditis associated with foot-and-mouth disease virus in lambs

(2011) Mustafa Yavuz Gulbahar et al.   Journal of Veterinary Science

Proteomic Signatures of Human Oral Epithelial Cells in HIV-Infected Subjects

(2011) Elizabeth Yohannes et al.   PLoS One

Pathogen Recognition Receptor Signaling Accelerates Phosphorylation-Dependent Degradation of IFNAR1

(2011) Juan Qian et al.   PLoS Pathogens

Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method

(2010) T.-C. Chou   CANCER RESEARCH

Curcumin inhibits hepatitis B virus via down-regulation of the metabolic coactivator PGC-1α

(2010) Maya Mouler Rechtman et al.   FEBS LETTERS